logo
Three ex-hospital chiefs arrested for manslaughter in Letby case

Three ex-hospital chiefs arrested for manslaughter in Letby case

Daily Mail​16 hours ago
Three former bosses at the hospital where Lucy Letby murdered babies have been arrested on suspicion of gross negligence manslaughter, Cheshire Police announced today. The senior executives, who worked at the Countess of Chester Hospital during the neo-natal nurse's killing spree, were quizzed by detectives yesterday after being invited to attend separate police stations across Cheshire. They have since been bailed pending further enquiries.
Their arrests form part of Cheshire Constabulary's ongoing inquiry into corporate manslaughter at the NHS Trust, where Letby murdered seven premature infants and harmed seven more between June 2015 and June 2016. In March, Detective Superintendent Paul Hughes (pictured), confirmed the corporate manslaughter investigation, codenamed Operation Duet, had been widened to include 'the grossly negligent action or inaction of individuals.' He said 'those identified as suspects had been notified' but refused to confirm any names. The Mail is aware of the identities of those arrested but is not naming individuals.
Letby, 35, is serving 15 whole-life orders after being found guilty of murdering seven infants and attempting to murder seven others, with two attempts on one of her victims, at the hospital's neo-natal unit. She has twice had applications to challenge her convictions rejected by the Court of Appeal. According to an independent report, leaked to the Mail's Trial+ podcast, in March, babies' lives could have been saved if hospital bosses had acted sooner to remove Lucy Letby from working. The report, commissioned by the Countess after Letby was first arrested, in July 2018, found managers were 'inexperienced' and missed 14 opportunities to suspend the nurse because they became 'blinkered' to the possibility she was responsible.
Instead of alerting the police, they commissioned a series of ineffectual external investigations, which failed to get to the bottom of why babies were unexpectedly collapsing and dying, the document said. Executives also 'ostracised' and 'bullied' doctors when they continued to raise concerns and demand police be called in, the report, carried out by independent healthcare consultancy Facere Melius, which has been blocked from publication, concluded. Although the report does not specifically reveal which babies might have lived, it makes clear that, by February 2016, at least two senior executives at the hospital knew about the link between Letby and the infant deaths. She tried to kill four children, Babies K, L, M and N, and murdered two triplet brothers, Babies O and P, before being removed from frontline nursing in July that year. 'Earlier action potentially would have reduced the number of baby deaths,' the report said. 'Had different decisions been made the spike in baby deaths would have been picked up sooner internally and externally, and potentially, lives could have been saved.'
At the recent public inquiry, which is investigating Letby's crimes, senior management at the hospital faced serious criticism over their handling of the spike in deaths. In their closing speeches, in March, lawyers for the infants' families, accused executives of orchestrating a cover up to protect the reputation of the hospital, lying to the families and bullying the consultants who tried to raise the alarm. Peter Skelton KC, who represents seven of Letby's victims, said they displayed 'a form of individual and corporate self-protection that should have no place in the NHS.' Kate Blackwell KC, for the senior executives, said in her closing remarks that they now accepted they should have called in police sooner, but the barrister insisted it was never expressed to them in 'stark' terms that Letby was causing deliberate harm before June 2016 – when she attacked and murdered Babies O and P and was finally moved from frontline nursing into an administrative role.
Ms Blackwell said managers accepted they had failed to follow safeguarding policies, made mistakes in their communication with the babies' parents and that there was a breakdown in their relationship with the paediatricians, who should have been better supported. But she insisted all their decisions were taken 'in good faith' and they 'vociferously denied' claims they deliberately and knowingly 'harboured' a murderer or put the hospital's reputation before the safety of babies in their care. 'The senior managers have emphatically refuted the proposition that either their own reputation or that of the Trust was prioritised over safety,' she added. In law, an individual can be found guilty of gross negligence manslaughter if they negligently breach the duty of care they owe the person who died and it was 'reasonably foreseeable' that such a breach gave rise to a 'serious and obvious risk of death.' The circumstances of the breach also have to be 'truly exceptionally bad and so reprehensible' that it amounts to gross negligence.
Mr Hughes, senior investigating officer for Operation Duet, said: 'As part of our ongoing enquiries, on Monday 30th June three individuals who were part of the senior leadership team at the Countess of Chester Hospital in 2015-2016, were arrested on suspicion of gross negligence manslaughter. 'All three have subsequently been bailed pending further enquiries. 'Both the corporate manslaughter and gross negligence manslaughter elements of the investigation are continuing and there are no set timescales for these.'
He added that today's development does 'not impact on the convictions of Lucy Letby for multiple offences of murder and attempted murder.' 'Our investigation into the deaths and non-fatal collapses of babies at the neo-natal units of both the Countess of Chester Hospital and the Liverpool Women's Hospital between the period of 2012 to 2016 is also ongoing.' Letby, of Hereford, has always maintained she is innocent and in April her new defence team submitted evidence from a panel of international experts to the Criminal Cases Review Commission, the organisation that examines miscarriages of justice, in a bid to have her convictions overturned. The experts claim no murders took place and instead assert that the babies died or collapsed because of natural causes or poor care.
Following the announcement of the arrests, Mark McDonald, Letby's new defence barrister, called for another inquiry into the 'failings of the neonatal and paediatric medical care unit at the Countess of Chester Hospital.' 'Yet another press release from the police at a very sensitive time when the CCRC are looking at the case of Lucy Letby,' Mr McDonald said. 'Despite this the concerns many have raised will not go away, and we will continue to publicly discuss them. 'The reality is that 26 internationally renowned experts have looked at this case and the lead expert has concluded that no crime was committed, no babies were murdered. What is needed is a proper and full public inquiry into the failings of the neonatal and paediatric medical care unit at the Countess of Chester hospital.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Man arrested on suspicion of murder after inmate found dead in prison cell
Man arrested on suspicion of murder after inmate found dead in prison cell

Sky News

time2 hours ago

  • Sky News

Man arrested on suspicion of murder after inmate found dead in prison cell

A man has been arrested on suspicion of murder after an inmate was found dead inside his prison cell. West Mercia Police said it received a report from HMP Stoke Heath in Shropshire that a man in his 40s had been found dead at about 7.40am yesterday. A 26-year-old man was arrested in connection with the incident after officers attended the prison, and he remains in custody. Superintendent Carl Moore said: "Our thoughts are with the family of the man who has lost his life. "An investigation has begun to establish the full circumstances of his death." HMP Stoke Heath is a men's Category C prison that houses nearly 800 inmates. In its last unannounced inspection in 2023, it was given the highest rating for keeping prisoners safe by HM Inspectorate of Prisons.

Battle re-enactor stabbed in face at Bodiam Castle weapons display
Battle re-enactor stabbed in face at Bodiam Castle weapons display

Times

time2 hours ago

  • Times

Battle re-enactor stabbed in face at Bodiam Castle weapons display

A medieval battle re-enactor was left seriously injured at a National Trust property over the weekend after a sword pierced his face through the visor of his helmet. The 37-year-old man from Horsham, West Sussex, was taken to the Royal Sussex County Hospital in Brighton following the accident at Bodiam Castle, near Robertsbridge, East Sussex, on Sunday. Sussex police are appealing for witnesses after the man, who has not been identified, was injured during a 'living history demonstration' at the 14th-century moated castle. Re-enactors in full battle dress costume The Company of the Phoenix, a 15th-century re-enactment group based in Eastbourne, who specialise in 'all aspects of medieval warfare' and boast of having an 'extensive weapons display', were scheduled to perform at the castle on Sunday as part of a medieval encampment weekend. Sussex police said: 'A 37-year-old man, from Horsham, was wearing body armour when his opponent re-enactor's sword entered his visor during a combat re-enactment just before 3pm. He suffered a head injury and he is currently in a serious condition at the Royal Sussex County Hospital in Brighton.' Detective Inspector Barry Chandler, of Sussex Police, said the force was 'treating the incident as an accident and we are offering support to [the man's] family'. He added: 'His opponent, a 36-year-old man also from Horsham, and the organisers are helping us with our inquiries. We know the re-enactment had drawn a large crowd and understand that anyone who witnessed the scene could have found this distressing. 'We are appealing to anyone who has photographs or videos of the interaction that led to the injury to contact us so we can gain a clear understanding of what happened.' A National Trust spokeswoman said: 'Following the accident at National Trust's Bodiam Castle in Sussex on Sunday June 29, our thoughts and concerns are with the injured man, his family and friends. 'The safety and wellbeing of everyone on site is extremely important to us, and we are co-operating fully with the relevant authorities. As this is a police matter we are unable to comment further.'' Concerned spectators took to social media to ask the National Trust about the condition of the injured re-enactor. Agatha Dratwa, who witnessed the incident, wrote on Facebook: 'Is the fella who got injured yesterday in the knights fight ok? Would be good to get some info please, it looked serious and we are all worried.' The National Trust responded: 'Thank you for your concern. Like you, our very best wishes are with the injured person, their family and friends. At this time, we don't have any further information to share.' Bodiam Castle was built in 1385 by Sir Edward Dalyngrigge, a former knight of Edward III, to defend the area against possible French invasion during the Hundred Years' War.

Breast cancer patients ‘denied life-extending drugs because of unfair system'
Breast cancer patients ‘denied life-extending drugs because of unfair system'

Rhyl Journal

time3 hours ago

  • Rhyl Journal

Breast cancer patients ‘denied life-extending drugs because of unfair system'

Breast Cancer Now has demanded 'immediate action' from Health Secretary Wes Streeting, urging him to scrap spending restraints. It is also calling for the NHS spending watchdog the National Institute for Health and Care Excellence (Nice) to lower the bar for what it classes as a very severe health condition. Nice's severity modifier, introduced in 2022, gives treatment for more severe illnesses more weight, meaning the health benefits of certain drugs are valued more highly and more likely to be recommended for NHS use. According to Nice, the process raises the threshold for what it considers to be a cost-effective treatment, meaning it can give more expensive drugs the green light. However, a new report from Breast Cancer Now claims the system means women with incurable breast cancer with months to live may be told their condition does not qualify for the most severe rating. The call comes after it emerged that the life-extending drug Enhertu will not be made available for women with incurable breast cancer on the NHS in England and Wales. In November, Nice said talks with manufacturers AstraZeneca and Daiichi Sankyo over the price of the medication had broken down for the third time with no agreement. Claire Rowney, chief executive at Breast Cancer Now, said: 'The terrifying reality is that unless urgent action is taken thousands of women in the UK with incurable secondary breast cancer could be denied access to vital life-extending treatments because of an unfair system. 'We're talking about patients missing out on access to cutting-edge, effective treatments that could give them more time to be there for special moments such as birthdays or seeing their children or grandchildren start school. 'Treatments, such as Enhertu, that patients in other countries, including Scotland, can access, giving them the chance to live longer. 'Women with secondary breast cancer tell us they feel their lives are being deprioritised by the changes to the system. 'We will not stand by and witness more drugs being rejected or not taken forward, when the devastating cost is thousands more people with secondary breast cancer across England, Wales and Northern Ireland having their lives cut short.' Paula Van Santen, 50, was diagnosed with secondary breast cancer in July 2022, two months after her diagnosis of primary breast cancer. The mother-of-three, from Banbury in Oxfordshire, said: 'Secondary breast cancer has changed the lives of both myself and my family beyond belief. Coming to terms with my diagnosis is the hardest part because I've had to grieve for the life I had, but also the life that I'm not going to have. 'If a new drug can give me another six months, if it gives me another year, it's worth it. 'It could allow me to see my daughter get to 21, see my children get married or meet grandchildren. Just to have a picture with a grandchild so they would know that I existed would be so precious. That's what this could give.' Ms Rowney called for 'change' and said Mr Streeting should scrap 'opportunity-cost neutral' restraints. Opportunity cost neutrality in the Nice severity modifier aims to ensure the new system does not require more or less overall NHS funding than the old one. According to the Breast Cancer Now report, this is 'at the root of the issues with the modifier'. It added: 'It pits end-of-life cancer treatments against other severe conditions like cystic fibrosis in a way that's reductive and unfair to patients. And, ultimately, it creates barriers to the approval of drugs for advanced cancers.' Ms Rowney said: 'The system for deciding whether drugs are approved for use on the NHS must change now. 'We're calling for immediate action from Wes Streeting, Secretary of State for Health and Social Care, to urgently scrap 'opportunity-cost neutral' restraints and for Nice to lower the bar for what it defines as 'a severe condition'. And we stand ready to work with them.' Dr Samantha Roberts, chief executive of Nice, welcomed the report from Breast Cancer Now, saying: 'The independent analysis we commissioned recently showed the new severity weighting is working as intended and expected. 'It is able to be applied more widely – for example to treatments for cystic fibrosis, hepatitis D and Duchenne muscular dystrophy – and has contributed to an increase in positive decisions for cancer medicines and non-cancer medicines. 'And other breast cancer treatments have been recommended since we introduced the severity modifier – including for advanced breast cancer. 'We remain deeply disappointed that we were unable to recommend Enhertu for HER2-low advanced breast cancer. We know this was devastating to all those hoping for a different answer. 'It remains the only breast cancer treatment we have been unable to recommend in seven years.' A Department of Health and Social Care spokesperson said the upcoming 10-year health plan will 'transform the NHS and improve care for those facing cancer'. 'This includes rolling out DIY screening kits for cervical cancer, more radiotherapy machines in every region and opening more Community Diagnostic Centres closer to where people live,' they added. 'We know how disappointing it is to many families that the manufacturers of Enhertu are unwilling to sell this life-extending treatment to the NHS at a fair and reasonable price. Our door remains open to supporting the introduction of medicines at a cost-effective price.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store